MedPage Today

Evolving Role of PSMA-PET in Metastatic Hormone-Sensitive Prostate Cancer: More Questions Than Answers?

or on the link below. Although most men with metastatic hormone-sensitive prostate cancer (mHSPC) die of prostate cancer (PCa), there remains significant outcome variability, with approximately 18.5% ...
ascopubs.org

Performance of a blood-based liquid biopsy test to detect PSMA expression on circulating tumor cells in men with metastatic prostate cancer.

Natural killer cell activity in patients with metastatic castration-resistant prostate cancer treated with enzalutamide. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary Cancers ...
ascopubs.org

Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?

Leveraging Circulating Tumor DNA to Optimize the Initial Management of Childhood Renal Tumors Although most men with metastatic hormone-sensitive prostate cancer (mHSPC) die of prostate cancer (PCa), ...
Business Insider

Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging

Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 medicines in development Quantitative PSMA-PET ...